Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Get Free Report) saw a significant increase in short interest in the month of June. As of June 30th, there was short interest totalling 120,100 shares, an increase of 14.9% from the June 15th total of 104,500 shares. Based on an average daily trading volume, of 57,500 shares, the short-interest […]
Shares of Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Get Free Report) have earned an average recommendation of “Buy” from the seven brokerages that are presently covering the firm, Marketbeat.com reports. Seven equities research analysts have rated the stock with a buy recommendation. The average 1-year price target among brokers that have issued ratings on the stock […]
Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Given Average Recommendation of "Buy" by Brokerages themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Free Report) was the recipient of a significant decline in short interest during the month of June. As of June 15th, there was short interest totalling 104,500 shares, a decline of 56.8% from the May 31st total of 241,900 shares. Based on an average daily trading volume, of 71,400 shares, […]
Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Free Report) was the target of a significant decline in short interest in June. As of June 15th, there was short interest totalling 104,500 shares, a decline of 56.8% from the May 31st total of 241,900 shares. Based on an average daily volume of 71,400 shares, the days-to-cover ratio is […]